Undergraduate Research by Analisa Stephens

Slides:



Advertisements
Similar presentations
Hershey and Chase confirmed that DNA, and not protein, is the hereditary material.
Advertisements

Plague CDC, AFIP. Diseases of Bioterrorist Potential Learning Objectives Describe the epidemiology, mode of transmission, and presenting symptoms of disease.
Developed by SHS Science Department
YERSINIA AND PASTEURELLA
Plague in Humans: A Bubo Formed in the Groin
Yersinia Non lactose fermenting Gram negative rods
Zoonotic infection. Causative agents of the plague, tularemia, brucellosis and anthrax. Laboratory diagnostics and prophylaxis of diseases. Vinnitsa National.
Laboratory of Respiratory and Special Pathogens. History of the Laboratories Laboratory of Pertussis Laboratory of Respiratory and Special Pathogens Laboratory.
Evolution in action: The fitness effects of beneficial mutations in alternative environments Taylor M. Warren and Vaughn S. Cooper* University of New Hampshire,
Arthropod borne infectious disease
University of California,San Francisco 1 Department of Anesthesia and Perioperative Care Acute P. aeruginosa Infections- From Genes to the Bedside The.
بسم الله الرحمن الرحيم GENUS: YERSINIA Prof. Khalifa Sifaw Ghenghesh.
Overview of the Laboratory of Respiratory and Special Pathogens Michael Schmitt, Ph.D. Chief, Laboratory of Respiratory and Special Pathogens.
Vaccines development of Vibrio vulnificus
MENINGOCOCCAL DISEASE & PREVENTION Dr Deb Wilson Consultant in Communicable Disease Control 2001.
DNA: The Information Molecule How did scientists use evidence to discover that the DNA molecule contains information?
Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus Bobby Arnold Alex Cardenas Zeb Russo Loyola.
Chapter 12 DNA: The Genetic Material Identification of the Genetic Material (DNA) In 1928, an experiment unrelated to genetics led to the discovery of.
Distinguishing Strains Individual bacterial species and strains may be distinguished by: RFLP or rep-PCR analysis Protein profiling Immunological tests.
Introduction to Immunology & Lymphoid System Immunology Unit Department of Pathology College of Medicine KSU.
Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus Bobby Arnold Alex Cardenas Zeb Russo Loyola.
Dr. Sheila Singh’s Laboratory Lab overview Operating since August 2007 Located at the Stem Cell & Cancer Research Institute at McMaster Main Campus Research.
Nilufer I. Nurinova Dr. David Lo Dr. Victor G. J. Rodgers 08/20/2009
(insert screaming now)
Jacob Berg Advisor Jeffrey Adamovicz University of Wyoming Department of Microbiology Department of Veterinary Sciences Methods in Immunology for Brucella.
The Importance of Mitochondrial Morphology in Saccharomyces cerevisiae NSF EPSCoR Mentor: Dr. Peter Thorsness Molecular Biology Dept University of Wyoming.
Monoclonal Antibody Production Against Synthetic Peptides Representing PrP c and Recombinant Prion Proteins (rPrP) By Kaitlin McDaniel, Dept. of Molecular.
Reticulon variation and correlation to Nuclear Size Regulation
Microbial toxin There are several virulence factors which help to establish disease The virulence of some bacteria is thought to be aided by the production.
GENERAL IMMUNOLOGY PHT 324
Evaluation of Immune Protection Elicited by Recombinant Antigen EtsC
Increasing Variation through DNA Transfer
DCE SMART Team : The Bubonic Plague
CATEGORY: PATHOGENS & DISEASE
CATEGORY: PATHOGENS & DISEASE
The association between anti-PcrV titers and protective effects against P. aeruginosa in PcrV vaccinated mice Saeko Hamaoka1, Yoshifumi Naito1, Hideya.
Volume 72, Issue 2, Pages (July 2007)
Pneumococcal conjugate vaccine – Use of pneumococcal surface protein A (PspA) as carrier Dr Giovana Cappio Barazzone Centro de Biotecnologia
Molecular Therapy - Methods & Clinical Development
Bacterial Classification and Nomenclature
Figure 1 Protective effects of acellular pertussis vaccines (A–F) in the respiratory infection model. Mice were challenged by exposure to an aerosol of.
Zeyu Chen,Rong Guo,Jianghong Xu,Chuangjun Qiu
Investigating the role of Ca+2/calmodulin dependent kinase pathways
Yersinia pestis Gram-negative, non-motile
CATEGORY: PATHOGENS & DISEASE
Protein secretion: Getting folded proteins across membranes
Discussion Outline Cells of the Immune System.
Many body systems protect you from pathogens.
The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300  E.L. Brown, O. Dumitrescu,
Yersinia pestis B. Clark F2013 Modified by DYH
Antibiotics are designed to : cell walls and membranes
Yersinia pestis Yersinia; Gammaproteobacteria Gram-negative bacillus
DNA Ch. 10.
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Immunology.
Volume 4, Issue 4, Pages (October 2008)
Volume 39, Issue 6, Pages (December 2003)
CD46 Is a Cellular Receptor for Human Herpesvirus 6
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Host Parasite Relationship
Volume 72, Issue 2, Pages (July 2007)
Enterobacteriaceae Dr.Salma.
Lec 6 Monoclonal Antibody.
Volume 10, Issue 2, Pages (August 2011)
US Army Medical Research and Materiel Command
*p<0.05; **p<0.01; ***p<
Volume 22, Issue 1, Pages (January 2015)
Fig. 6 Multivalent DNA vaccine and protein antigen delivery by T4-AAV nanoparticles. Multivalent DNA vaccine and protein antigen delivery by T4-AAV nanoparticles.
Unassembled Ig Heavy Chains Do Not Cycle from BiP In Vivo but Require Light Chains to Trigger Their Release  Marc Vanhove, Young-Kwang Usherwood, Linda.
Expression of MtrE by wild-type and mtr120 mutant strains.
Presentation transcript:

In vitro Analysis of Differential Expression of the Yersinia pestis F1 capsule and V antigen Undergraduate Research by Analisa Stephens Mentored by Dr. Gerry Andrews Department of Veterinary Science, University of Wyoming

Outline Background Research Objectives Methods Results Conclusions Applications Acknowledgements

Background Yersinia pestis Gram-negative rod in family Enterobacteriaceae Bubonic and Pneumonic Plague Bubonic – 50% mortality Pneumonic – 100% mortality Flea bite or aerosol contact Varying growth conditions

Background Outer Membrane Proteins V antigen (Lcr) Virulence factors Environmentally regulated F1 capsule antigen Forms a large gel-like capsule on the cell surface Anti-phagocytic properties Encoded from a temperature-regulated operon Strains lacking F1 capsule are still virulent V antigen (Lcr) Transports virulence proteins out of the cell Modulates host immumological response Required for full virulence caf1R caf1M caf1A caf1 Ypcaf Operon

Background Dr. Rozak– F1 and V antigen based vaccines Vaccines F1 alone protective to <103 LD50’s in mice ag. 25C challenge Protection increased by 2 logs in mice ag 37C challenge V alone protective to 105 LD50’s in mice ag 25C challenge Protection reduced by 70% in mice ag 37C challenge Dr. Rozak– F1 and V antigen based vaccines Investigated links between expression and observed immunity

Research Objectives Determine expression of Lcr V antigen With F1 antigen Y. pestis strain CO92 Without F1 antigen Y. pestis strain C12

Methods Bacterial Growth Strains: CO92 and C12 HIB Media Over night culture at 25C Shift to 37C and 25C culture SLIM Assay - Suspension-labelling Immuno[assay] Anti-LcrV MAb anti-mouse IgG, alkaline phosphatase conjugated pmpp A405

Results t=4 Y. pestis Co92 HIB Media OD600 1.42 A405 1.20 0.68 A405 0.36

Results Alternative hypothesis: Goes against original hypothesis Previously thought C12 would have more surface-exposed V Alternative hypothesis: Cell-free V antigen “trapped” by F1 capsule F1 Capsule Cell-free V antigen C12 Cell CO92 Cell Cell membrane -bound V Ag

Conclusions Y. pestis causes plague Two different transmission modes Effects of growing conditions (temperature) Current vaccines impacted by these conditions Further testing required to expanded on preliminary results Future research being done this summer

Application Effective Vaccines Expand current knowledge-base F1 and V Combined as one hybrid protein …”F1-V” protective to >107 LD50’s in mice ag. 25C and 37C challenge IND status; in clinical trials Expand current knowledge-base

Acknowledgements Wyoming’s NSF EPSCoR Program University of Wyoming College of Agriculture Department of Veterinary Science Dr. Gerry Andrews Jessie Pate Giulia Vernati USAMRIID Group (Dr. Rozak)